A 36 year old female is brought into your ED department with acute shortness of breath. She is unable to provide any history due to her tachypnoea. She is sitting upright in bed grasping the bed sides. She has a respiratory rate of 30 breaths per minute, has a GCS of 15, is afebrile and has a BP of 90/60mmHg. She is using accessory muscles. On auscultation, she has widespread expiratory wheeze spread throughout both lung fields.
1) What are the differential diagnoses for her presentation?
The rest of the viva focussed on the assessment and management of bronchial asthma
Most likely:
Less likely:
This is a variant of Question 2 from the second paper of 2001, which was a question about the differential diagnosis of wheeze. Causes of widespread wheeze may include:
Extrathoracic causes
- Anaphylaxis
- Vocal cord paralysis
- Laryngeal stenosis
- Goiter with thoracic inlet obstruction
- Anxiety with hyperventilation
Intrathoracic central airway causes
- Tracheal stenosis
- Mediastinal tumours
- Hyperdynamic airway collapse due to tracheomalacia
- Mucus plugs
- Thoracic aortic aneurysm
- Foreign body inhalation
Intrathoracic lower airway causes
- Bronchitis or bronchiolitis
- COPD
- Pulmonary oedema - "cardiac asthma"
- Airway distortion due to mechanical causes, eg. bronchial mass, bronchiectasis, pneumothorax
- Exposure to inhaled irritant or corrosive agent, and this includes the aspiration of gastric contents
Historical features:
Examination findings:
Pulmonary function test data:
ABG data:
The presence of respiratory acidosis suggests that the patient is tiring
The absence of raised lactate suggests that nebulised salbutamol is ineffective
(air entry is too poor).
Theoretical benefits in asthma:
Disadvantages
Lim et al, (2012) ended up scraping together five studies - which only had n=206 in total. Of the 90-or so patients in two RCTs analysed by Lim et al, only two required intubation. There were no deaths in either group. How can you demonstrate a mortality benefit if nobody is dying?..
Alternatively, the candidate interpret see this question as "when would you intubate the asthmatic?" That will be the next question:
These are the consensus indications for intubation quoted by Brenner et al (2009).
Most likely
Less likely:
The candidates need to mention something about dynamic hyperinflation here.
(this is based on the college answer to Question 1 from the first paper of 2015)
The options for mucolytic choice are
Evidence in support of this practice is lacking:
Selected patients may still benefit, but:
At this late stage in the viva, anything goes - if they had made it this far in 10 minutes they can go on about ECMO as much a they like.
Disclaimer: the viva stem above may be an original CICM stem, acquired from their publicly available past papers. Or, perhaps it is a slightly altered version of the original CICM stem. Or, it is a completely original viva stem, concocted by the monstrously amoral author of Deranged Physiology for nothing more than his own personal amusement. In either case, because the college do not make the main viva text or marking criteria available, almost everything here has been confabulated. It might sound like a plausible viva and it could be used for the purpose of practice, but all should be aware that it does not represent the "true" canonical CICM viva station.
Oh's Intensive Care manual: Chapter 35 (pp. 401) Acute severe asthma by David V Tuxen and Matthew T Naughton.
Stow, Peter J., et al. "Improved outcomes from acute severe asthma in Australian intensive care units (1996–2003)." Thorax 62.10 (2007): 842-847.
Sekiya, Kiyoshi, et al. "Clinical evaluation of severe asthma attacks requiring tracheal intubation and mechanical ventilation." Allergology International 58 (2009): 289-294.
Sandford, Andrew J., et al. "Polymorphisms in the IL4, IL4RA, and FCERIB genes and asthma severity." Journal of Allergy and Clinical Immunology 106.1 (2000): 135-140.
McFadden Jr, E. R. "Acute severe asthma." American journal of respiratory and critical care medicine 168.7 (2003): 740-759.
Bousquet, Jean, et al. "Uniform definition of asthma severity, control, and exacerbations: document presented for the World Health Organization Consultation on Severe Asthma." Journal of Allergy and Clinical Immunology126.5 (2010): 926-938.
Perrin, Kyle, et al. "Randomised controlled trial of high concentration versus titrated oxygen therapy in severe exacerbations of asthma." Thorax 66.11 (2011): 937-941.
Rodrigo, Gustavo J., et al. "Effects of Short-term 28% and 100% Oxygen on Paco2 and Peak Expiratory Flow Rate in Acute AsthmaA Randomized Trial."CHEST Journal 124.4 (2003): 1312-1317.
Sellers, W. F. S. "Inhaled and intravenous treatment in acute severe and life-threatening asthma." British journal of anaesthesia 110.2 (2013): 183-190.
Cates, C. J., E. J. Welsh, and B. H. Rowe. "Holding chambers (spacers) versus nebulisers for delivery of beta-agonist relievers in the treatment of an asthma attack." (2013).
Teoh, Laurel, et al. "Anticholinergic therapy for acute asthma in children."Cochrane Database Syst Rev 4 (2012).
Coupe, M. O., et al. "Nebulised adrenaline in acute severe asthma: comparison with salbutamol." European journal of respiratory diseases 71.4 (1987): 227-232.
Albertson, T. E., et al. "Pharmacotherapy of critical asthma syndrome: current and emerging therapies." Clinical reviews in allergy & immunology (2014): 1-24.
Powell, Colin, et al. "Magnesium sulphate in acute severe asthma in children (MAGNETIC): a randomised, placebo-controlled trial." The Lancet Respiratory Medicine 1.4 (2013): 301-308.
Shan, Zhilei, et al. "Intravenous and nebulized magnesium sulfate for treating acute asthma in adults and children: a systematic review and meta-analysis."Respiratory medicine 107.3 (2013): 321-330.
Wigmore, T., and E. Stachowski. "A review of the use of heliox in the critically ill." Critical Care and Resuscitation 8.1 (2006): 64.
Rodrigo, G., et al. "Heliox for nonintubated acute asthma patients." Cochrane Database Syst Rev 4 (2006).
Jat, Kana R., and Deepak Chawla. "Ketamine for management of acute exacerbations of asthma in children." Cochrane Database of Systematic Reviews 11 (2012).
Howton, Joseph C., et al. "Randomized, double-blind, placebo-controlled trial of intravenous ketamine in acute asthma." Annals of emergency medicine 27.2 (1996): 170-175.
Vaschetto, R., et al. "Inhalational anesthetics in acute severe asthma." Current drug targets 10.9 (2009): 826-832.
Lobaz, S., and M. Carey. "Rescue of acute refractory hypercapnia and acidosis secondary to life-threatening asthma with extracorporeal carbon dioxide removal (ECCO2R)." JICS 12.2 (2011): 140-142.
Leiba, Adi, et al. "Early administration of extracorporeal life support for near fatal asthma." IMAJ-RAMAT GAN- 5.8 (2003): 600-602.
Samaria, J. K. "Role Of Niv In Acute Respiratory Failure Due To Asthma: Effectiveness And Predictors Of Failure." Am J Respir Crit Care Med 183 (2011): A1365.
Op't Holt, Timothy B. "Additional Evidence to Support the Use of Noninvasive Ventilation in Asthma Exacerbation." Respiratory care 58.2 (2013): 380-382.
Green, Elyce, Paras Jain, and Maree Bernoth. "Noninvasive ventilation for acute exacerbations of asthma: A systematic review of the literature." Australian Critical Care (2017).
SAMARIA, JAI K., and Satyadeo Chaubey. "Role Of NIV In Acute Respiratory Failure Due To Asthma: Effectiveness And Predictors Of Failure." A34. MANAGEMENT OF ASTHMA, RHINITIS, AND SINUSITIS. American Thoracic Society, 2011. A1365-A1365.
Brenner, Barry, Thomas Corbridge, and Antoine Kazzi. "Intubation and mechanical ventilation of the asthmatic patient in respiratory failure." Proceedings of the American Thoracic Society 6.4 (2009): 371-379.
Busse, W. W., et al. "Expert panel report 3: Guidelines for the diagnosis and management of asthma." Washington, DC: US Department of Health and Human Services, National Heart Lung and Blood Institute (2007): 1-417.